Yuta Suzuki

2.7k citations

48 papers · 2.2k indexed · 1 hit paper · h-index 23

Co-authors: Hiroshi Ishihara Yasutomo Segawa Kyoko Nozaki Makoto Yamashita Makoto Komiyama Yan Xu Yasumasa Hamada Tetsuhiro Nemoto
Topics: RNA Interference and Gene Delivery (16 papers)Advanced biosensing and bioanalysis techniques (13 papers)DNA and Nucleic Acid Chemistry (10 papers)
Cited by: Organic Chemistry Inorganic Chemistry Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Angewandte Chemie International Edition
Partner nations: Japan United States

In The Last Decade

Yuta Suzuki

46 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs

2021 207 citations Yuta Suzuki, Hiroshi Ishihara Drug Metabolism and Pharmacokinetics profile →

Peers

Countries citing papers authored by Yuta Suzuki

Since Specialization

Citations

This map shows the geographic impact of Yuta Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuta Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuta Suzuki more than expected).

Fields of papers citing papers by Yuta Suzuki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuta Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuta Suzuki. The network helps show where Yuta Suzuki may publish in the future.

Co-authorship network of co-authors of Yuta Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuta Suzuki. A scholar is included among the top collaborators of Yuta Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuta Suzuki. Yuta Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Species-specific gene expression manipulation in humanized livers of chimeric mice via siRNA-encapsulated lipid nanoparticle treatment 2025 ·Molecular Therapy — Methods & Clinical Development ·Kazuto Yamazaki,Kenji Kubara,(unknown),(unknown),(unknown),Yuji Mano,Kaoru Mitsuhashi,Chihiro Yamasaki,Yuji Ishida,Chise Tateno,Yuta Suzuki	2
2	Ionizable lipid chemistry in lipid nanoparticles determines delivery efficiency to hepatic stellate cells 2025 ·Journal of Controlled Release ·(unknown),Kenji Kubara,(unknown),(unknown),Yuta Suzuki	0
3	Multivalent mannose-conjugated siRNA causes robust gene silencing in pancreatic macrophages in vivo 2023 ·European Journal of Pharmaceutics and Biopharmaceutics ·Kazuto Yamazaki,Kenji Kubara,Yuta Suzuki,Taro Hihara,Daisuke Kurotaki,(unknown),Masashi Ito,Kappei Tsukahara	9
4	Identification of potent siRNA targeting complement C5 and its robust activity in pre-clinical models of myasthenia gravis and collagen-induced arthritis 2023 ·Molecular Therapy — Nucleic Acids ·Yoshikazu Kuboi,Yuta Suzuki,(unknown),Chiyuki Matsui,(unknown),Tomoya Nakatani,(unknown),Yoshinori Takahashi,(unknown),(unknown),(unknown),(unknown)	9
5	Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice 2023 ·Molecular Therapy — Nucleic Acids ·Kazuto Yamazaki,Kenji Kubara,(unknown),Keita Kondo,Yuta Suzuki,(unknown),Kaoru Mitsuhashi,Masashi Ito,Kappei Tsukahara	23
6	Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugsbreakdown → 2021 ·Drug Metabolism and Pharmacokinetics ·Yuta Suzuki,Hiroshi Ishihara	207
7	Irf5 siRNA-loaded biodegradable lipid nanoparticles ameliorate concanavalin A-induced liver injury 2021 ·Molecular Therapy — Nucleic Acids ·(unknown),Daisuke Kurotaki,Yuta Suzuki,Hiroshi Ishihara,Tatsuma Ban,Go Sato,(unknown),Hideyuki Yanai,Tadatsugu Taniguchi,Kappei Tsukahara,Tomohiko Tamura	17
8	PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production 2020 ·International Journal of Pharmaceutics ·Takuya Suzuki,Yuta Suzuki,Taro Hihara,Kenji Kubara,Keita Kondo,Kenji Hyodo,Kazuto Yamazaki,Tatsuhiro Ishida,Hiroshi Ishihara	161
9	Unprecedented Asymmetric Epoxidation of Isolated Carbon–Carbon Double Bonds by a Chiral Fluorous Fe(III) Salen Complex: Exploiting Fluorophilic Effect for Catalyst Design 2019 ·European Journal of Organic Chemistry ·Y. Kobayashi,(unknown),Yuki Watanabe,(unknown),(unknown),Yuta Suzuki,Yukihiro Yoshida,Takayuki Shioiri,Masato Matsugi	22
10	Synthesis of pyrrole-imidazole polyamide oligomers based on a copper-catalyzed cross-coupling strategy 2017 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Tasuku Murakami,Rui Qin,Yuta Suzuki,Ken‐ichi Shinohara,Atsushi Kaneda,Tetsuhiro Nemoto	3
11	Biodegradable lipid nanoparticles induce a prolonged RNA interference-mediated protein knockdown and show rapid hepatic clearance in mice and nonhuman primates 2017 ·International Journal of Pharmaceutics ·Yuta Suzuki,Kenji Hyodo,Takuya Suzuki,Yohei Tanaka,Hiroshi Kikuchi,Hiroshi Ishihara	52
12	Structure, activity and uptake mechanism of siRNA-lipid nanoparticles with an asymmetric ionizable lipid 2016 ·International Journal of Pharmaceutics ·Yuta Suzuki,Hiroshi Ishihara	47
13	siRNA-lipid nanoparticles with long-term storage stability facilitate potent gene-silencing in vivo 2015 ·Journal of Controlled Release ·Yuta Suzuki,Kenji Hyodo,(unknown),Hiroshi Ishihara	59
14	Finding a human telomere DNA–RNA hybrid G-quadruplex formed by human telomeric 6-mer RNA and 16-mer DNA using click chemistry: A protective structure for telomere end 2014 ·Bioorganic & Medicinal Chemistry ·Yan Xu,Yuta Suzuki,Takumi Ishizuka,(unknown),Xiao Liu,Tetsuya Hayashi,Makoto Komiyama	16
15	Palladium‐Catalyzed Intramolecular ipso‐Friedel–Crafts Alkylation of Phenols and Indoles: Rearomatization‐Assisted Oxidative Addition 2013 ·Angewandte Chemie International Edition ·Tetsuhiro Nemoto,(unknown),Takuya Yokosaka,Yuta Suzuki,(unknown),Yasumasa Hamada	166
16	Direct Catalytic Asymmetric Intramolecular Conjugate Addition of Thioamide to α,β‐Unsaturated Esters 2011 ·Chemistry - A European Journal ·Yuta Suzuki,Ryo Yazaki,Naoya Kumagai,Masakatsu Shibasaki	17
17	Telomeric repeat-containing RNA structure in living cells 2010 ·Proceedings of the National Academy of Sciences ·Yan Xu,Yuta Suzuki,Kenichiro Ito,Makoto Komiyama	154
18	Molecular basis of human telomere DNA/RNA structure and its potential application 2009 ·Nucleic Acids Symposium Series ·Yan Xu,Yuta Suzuki,Kenichi Kaminaga,Makoto Komiyama	3
19	Prompt site-selective DNA hydrolysis by Ce(iv)–EDTA using oligonucleotide multiphosphonate conjugates 2008 ·Organic & Biomolecular Chemistry ·Tuomas Lönnberg,Yuta Suzuki,Makoto Komiyama	18
20	Ce(IV)-Catalyzed Site-Selective DNA Hydrolysis Using Tris- and Tetrakismethylenephosphonate-Modified Oligonucleotides 2007 ·Nucleic Acids Symposium Series ·Tuomas Lönnberg,Yuta Suzuki,Makoto Komiyama	2

About Yuta Suzuki

Yuta Suzuki is a scholar working on Organic Chemistry, Cancer Research and Molecular Biology, having authored 48 papers that have together received 2.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (16 papers), Advanced biosensing and bioanalysis techniques (13 papers) and DNA and Nucleic Acid Chemistry (10 papers). The work is most often cited by research in Organic Chemistry (1.2k citations), Inorganic Chemistry (414 citations) and Molecular Biology (986 citations). Yuta Suzuki has collaborated with scholars based in Japan and United States. Frequent co-authors include Hiroshi Ishihara, Yasutomo Segawa, Kyoko Nozaki, Makoto Yamashita, Makoto Komiyama, Yan Xu, Yasumasa Hamada, Tetsuhiro Nemoto, Ryo Yazaki and Masakatsu Shibasaki. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact